Acetyl-CoA Carboxylase Inhibition as a Therapeutic Tool in the Battle Against NASH: Hitting More Than Just One Mechanism?

Cell Mol Gastroenterol Hepatol. 2020;10(4):859-861. doi: 10.1016/j.jcmgh.2020.07.002. Epub 2020 Jul 27.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acetyl-CoA Carboxylase*
  • Humans
  • Non-alcoholic Fatty Liver Disease* / drug therapy

Substances

  • Acetyl-CoA Carboxylase